The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. Various strategies can be employed to antibody titer, including process parameter optimization, media optimization, and implementation of perfusion technologies. Fine-tuning growth paramet